A 10-year retrospective case-control study for IgA nephropathy after tonsillectomy

被引:3
|
作者
Akagi, H [1 ]
Fukushima, K [1 ]
Kosaka, M [1 ]
Doi, A [1 ]
Okano, M [1 ]
Kariya, S [1 ]
Nishizaki, K [1 ]
Masuda, Y [1 ]
机构
[1] Natl Minami Okayama Hosp, Dept Otolaryngol, Okayama 7010304, Japan
来源
CURRENT TOPICS ON TONSILS AND MUCOSAL BARRIERS OF UPPER AIRWAYS | 2003年 / 1257卷
关键词
case-control study; IgA nephropathy; tonsillectomy; renal biopsy; renal survival rate;
D O I
10.1016/S0531-5131(03)01156-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A retrospective case-control study of 71 patients with IgA nephropathy was performed to evaluate the long-term prognostic effect of tonsillectomy. Forty-one patients (19 males and 22 females) underwent tonsillectomy (Group A) and 30 patients (13 males and 17 females) did not (Group B). These patients were followed for more than 10 years after renal biopsy. The average age at the initial renal biopsy was 29.78 years in Group A and 33.0 years in Group B. The average follow-up period was 13 years and 3 months in Group A, and 12 years and 7 months in Group B. Glomerular damage demonstrated on renal biopsy was more extensive in Group A than in Group B. Renal prognosis after 10 years of follow-up was compared between these two groups. The clinical remission rate was 24.4% in Group A and 13.3% in Group B; the stable renal function rate was 82.9% in Group A and 70.0% in Group B; and the renal survival rate was 95.1% in Group A and 73.3% in Group B. The renal survival rate in Group A was significantly higher than that in Group B (p < 0.05). (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [1] Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study
    Li, Yan
    Wan, Qi
    Lan, Zhixin
    Xia, Ming
    Liu, Haiyang
    Chen, Guochun
    He, Liyu
    Wang, Chang
    Liu, Hong
    PEERJ, 2022, 10
  • [2] Risk factors for IgA nephropathy: A case-control study in Japan
    Wakai, K
    Kawamura, T
    Matsuo, S
    Hotta, N
    Ohno, Y
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) : 738 - 745
  • [3] Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study
    Yang, Ya-zi
    Shi, Su-Fang
    Chen, Yu-Qing
    Chen, Min
    Yang, Yi-He
    Xie, Xin-Fang
    Zou, Rong
    Lv, Ji-Cheng
    Liu, Li-Jun
    Zhang, Hong
    CLINICAL KIDNEY JOURNAL, 2015, 8 (05): : 482 - 488
  • [4] Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy
    Kataoka, Hiroshi
    Ohara, Mamiko
    Honda, Kazuho
    Mochizuki, Takahiro
    Nitta, Kosaku
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (12) : 3937 - U674
  • [5] Risk factors for IgA nephropathy: A case-control study with incident cases in Japan
    Wakai, K
    Nakai, S
    Matsuo, S
    Kawamura, T
    Hotta, N
    Maeda, K
    Ohno, Y
    NEPHRON, 2002, 90 (01) : 16 - 23
  • [6] Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study
    Tang, Chen
    Lv, Ji-Cheng
    Shi, Su-Fang
    Chen, Yu-Qing
    Liu, Li-Jun
    Zhang, Hong
    BMC NEPHROLOGY, 2020, 21 (01)
  • [7] A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study
    Goto, Masashi
    Wakai, Kenji
    Kawamura, Takashi
    Ando, Masahiko
    Endoh, Masayuki
    Tomino, Yasuhiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 3068 - 3074
  • [8] Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study
    Chen Tang
    Ji-Cheng Lv
    Su-Fang Shi
    Yu-Qing Chen
    Li-Jun Liu
    Hong Zhang
    BMC Nephrology, 21
  • [9] Outcome of tonsillectomy for recurrent IgA nephropathy after kidney transplantation
    Koshino, Katsuhiro
    Ushigome, Hidetaka
    Sakai, Kazuki
    Suzuki, Tomoyuki
    Nobori, Syuji
    Okajima, Hideaki
    Masuzawa, Naoko
    Yoshimura, Norio
    CLINICAL TRANSPLANTATION, 2013, 27 : 22 - 28
  • [10] Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case-control study
    Wang, Meng
    Ma, Jianfei
    Yao, Li
    Fan, Yi
    CLINICAL KIDNEY JOURNAL, 2024, 17 (10)